Biểu đồ giá cổ phiếu PSTV
PSTV Thu nhập
Plus Therapeutics Inc
$5.95
-0.66%
$-0.04
Khi đóng cửa: Apr 28, 16:00:00 GMT-4
$6.19
4.04%
$0.24
Phiên trước giờ: Apr 29, 07:18:18 GMT-4
Quay lại
Plus Therapeutics Inc (PSTV) Thu nhập
Thống kê chính
Giá đóng cửa trước
$5.99
Giá mở cửa
$5.96
Phạm vi ngày
$5.68 - $6.19
Phạm vi 52 tuần
$2.9 - $30.5
Khối lượng
112.5K
Khối lượng trung bình
443.2K
Tỷ suất cổ tức
--
EPS (TTM)
-1.25
Vốn hóa thị trường
$42.4M
PSTV là gì?
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The company is headquartered in Austin, Texas. The company went IPO on 2000-08-09. The firm is engaged in developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. Combining image-guided local beta radiation and targeted drug delivery approaches, it is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). Its lead radiotherapeutic candidate, REYOBIQ (rhenium (186Re) obisbemeda), is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC) by direct localized delivery utilizing approved standard-of-care tissue access such as with convection-enhanced delivery (CED) and intraventricular brain (Ommaya reservoir) catheters. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers including primary and secondary liver cancers via intra-arterial injections.
